EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
137 hedge funds and large institutions have $1.17B invested in Eagle Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
18% more funds holding
Funds holding: 116 → 137 (+21)
9% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 33
Holders
137
Holding in Top 10
6
Calls
$17.5M
Puts
$6.33M
Top Buyers
| 1 | +$48.3M | |
| 2 | +$39.8M | |
| 3 | +$25.1M | |
| 4 |
PC
PointState Capital
New York
|
+$21.3M |
| 5 |
JCI
Jet Capital Investors
New York
|
+$9.44M |
Top Sellers
| 1 | -$29.6M | |
| 2 | -$27.8M | |
| 3 | -$21.3M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$18.7M |
| 5 |
GE
General Electric
Evendale,
Ohio
|
-$13.1M |